Vitamin D signaling regulates proliferation, differentiation, and myotube size in C2C12 skeletal muscle cells

Endocrinology

Volumn 155, Issue 2, 2014, Pages 347-357

  Girgis, Christian M ^a,b   Clifton Bligh, Roderick J ^b,c,d   Mokbel, Nancy ^a   Cheng, Kim ^a   Gunton, Jenny E ^a,b,e,f  

^a GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b University of Sydney   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

^d ROYAL NORTH SHORE HOSPITAL   (Australia)

^e WESTMEAD HOSPITAL   (Australia)

^f UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

1,25 HYDROXYVITAMIN D; 25 HYDROXYVITAMIN D; CYCLIN D1; CYTOCHROME P450 2A1; CYTOCHROME P450 2B1; MYC PROTEIN; MYOGENIN; MYOSTATIN; RETINOBLASTOMA PROTEIN; UNCLASSIFIED DRUG; VITAMIN D RECEPTOR;

ARTICLE; AUTOREGULATION; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SIZE; CELL STIMULATION; CELL STRUCTURE; CONTROLLED STUDY; G1 PHASE CELL CYCLE CHECKPOINT; GENE EXPRESSION; LUCIFERASE ASSAY; MUSCLE CELL; MYOTUBE; PRIORITY JOURNAL; PROTEIN FOLDING; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SKELETAL MUSCLE;

ANIMALS; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; GENE EXPRESSION; MICE; MUSCLE FIBERS, SKELETAL; MUSCLE, SKELETAL; RECEPTORS, CALCITRIOL; SIGNAL TRANSDUCTION; VITAMIN D;

EID: 84893169247     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2013-1205     Document Type: Article

References (55)

1. GirgisCM,Clifton-Bligh RJ, HamrickMW,HolickMF,Gunton JE. The roles of vitamin D in skeletal muscle: form, function, and metabolism. Endocr Rev. 2013;34: 33-83.
2. Sato Y, Iwamoto J, Kanoko T, Satoh K. Low-dose vitamin D prevents muscular atrophy and reduces falls and hip fractures in women after stroke: a randomized controlled trial. Cerebrovasc Dis. 2005; 20: 187-192.
3. Hess AF. The prevention and cure of rickets by sunlight. AmJ Public Health (N Y). 1922;12: 104-107.
4. Fluss J, Kern I, de Coulon G, Gonzalez E, Chehade H. Vitamin D deficiency: a forgotten treatable cause of motor delay and proximal myopathy. Brain Dev. 2012;pii:S0387-S7604(12)00303-8.
5. Endo I, Inoue D, Mitsui T, et al. Deletion of vitaminDreceptor gene in mice results in abnormal skeletal muscle development with deregulated expression of myoregulatory transcription factors. Endocrinology. 2003;144: 5138-5144.
6. Kalueff AV, Lou YR, Laaksi I, Tuohimaa P. Impaired motor performance in mice lacking neurosteroid vitamin D receptors. Brain Res Bull. 2004;64: 25-29.
7. Burne TH, Johnston AN, McGrath JJ, Mackay-Sim A. Swimming behaviour and post-swimming activity in vitaminDreceptor knockout mice. Brain Res Bull. 2006;69: 74-78.
8. Wang Y, DeLuca HF. Is the vitamin D receptor found in muscle? Endocrinology. 2011;152: 354-363.
9. Bischoff HA, Borchers M, Gudat F, et al. In situ detection of 1,25- dihydroxyvitamin D3 receptor in human skeletal muscle tissue. Histochem J. 2001;33: 19-24.
10. Kislinger T, Gramolini AO, Pan Y, Rahman K, MacLennan DH, Emili A. Proteome dynamics during C2C12 myoblast differentiation. Mol Cell Proteomics. 2005;4: 887-901.
11. Moran JL, Li Y, Hill AA, Mounts WM, Miller CP. Gene expression changes during mouse skeletal myoblast differentiation revealed by transcriptional profiling. Physiol Genomics. 2002;10: 103-111.
12. Andrés V, Walsh K. Myogenin expression, cell cycle withdrawal, and phenotypic differentiation are temporally separable events that precede cell fusion upon myogenesis. J Cell Biol. 1996;132: 657-666.
13. Fujita H, Endo A, Shimizu K, Nagamori E. Evaluation of serum-free differentiation conditions for C2C12 myoblast cells assessed as to active tension generation capability. Biotechnol Bioeng. 2010;107: 894-901.
14. Conejo R, Valverde AM, Benito M, Lorenzo M. Insulin produces myogenesis in C2C12 myoblasts by induction of NF-κB and downregulation of AP-1 activities. J Cell Physiol. 2001;186: 82-94.
15. Erbay E, Chen J. The mammalian target of rapamycin regulates C2C12 myogenesis via a kinase-independent mechanism. J Biol Chem. 2001;276: 36079-36082.
16. Zhu GH, Huang J, Bi Y, et al. Activation ofRXRandRARsignaling promotes myogenic differentiation of myoblastic C2C12 cells. Differentiation. 2009;78: 195-204.
17. Cardús A, Parisi E, Gallego C, Aldea M, Fernández E, Valdivielso JM. 1,25-Dihydroxyvitamin D3 stimulates vascular smooth muscle cell proliferation through a VEGF-mediated pathway. Kidney Int. 2006;69: 1377-1384.
18. Garcia LA, King KK, Ferrini MG, Norris KC, Artaza JN. 1,25(OH)2Vitamin D3 stimulates myogenic differentiation by inhibiting cell proliferation and modulating the expression of promyogenic growth factors and myostatin in C2C12 skeletal muscle cells. Endocrinology. 2011;152: 2976-2986.
19. Khanna-Jain R, Vuorinen A, Sandor GK, Suuronen R, Miettinen S. Vitamin D3 metabolites induce osteogenic differentiation in human dental pulp and human dental follicle cells. J Steroid Biochem Mol Biol. 2010;122: 133-141.
20. Artaza JN, Sirad F, Ferrini MG, Norris KC. 1,25(OH)2Vitamin D3 inhibits cell proliferation by promoting cell cycle arrest without inducing apoptosis and modifies cell morphology of mesenchymal multipotent cells. J Steroid Biochem Mol Biol. 2010;119: 73-83.
21. Nakayama GR, Caton MC, Nova MP, Parandoosh Z. Assessment of the Alamar Blue assay for cellular growth and viability in vitro. J Immunol Methods. 1997;204: 205-208.
22. Cheng K, Delghingaro-Augusto V, Nolan CJ, et al. High passage MIN6 cells have impaired insulin secretion with impaired glucose and lipid oxidation. PLoS One. 2012;7:e40868.
23. Menaker RJ, Ceponis PJ, Jones NL. Helicobacter pylori induces apoptosis of macrophages in association with alterations in the mitochondrial pathway. Infect Immun. 2004;72: 2889-2898.
24. Mercer SE, Ewton DZ, Deng X, Lim S, Mazur TR, Friedman E. Mirk/Dyrk1B mediates survival during the differentiation of C2C12 myoblasts. J Biol Chem. 2005;280: 25788-25801.
25. Cheng K, Ho K, Stokes R, et al. Hypoxia-inducible factor-1α regulates β-cell function in mouse and human islets. J Clin Invest. 2010; 120: 2171-2183.
26. Lau SM, Lin S, Stokes RA, et al. Synergistic effects of genetic β-cell dysfunction and maternal glucose intolerance on offspring metabolic phenotype in mice. Diabetologia. 2011;54: 910-921.
27. Gunton JE, Delhanty PJ, Takahashi S, Baxter RC. Metformin rapidly increases insulin receptor activation in human liver and signals preferentially through insulin-receptor substrate-2. J Clin Endocrinol Metab. 2003;88: 1323-1332.
28. Wang Y, Becklund BR, DeLuca HF. Identification of a highly specific and versatile vitamin D receptor antibody. Arch Biochem Biophys. 2010;494: 166-177.
29. McGowan EM, Russell AJ, Boonyaratanakornkit V, et al. Progestins reinitiate cell cycle progression in antiestrogen-arrested breast cancer cells through the B-isoform of progesterone receptor. Cancer Res. 2007;67: 8942-8951.
30. Musgrove EA, Sergio CM, Loi S, et al. Identification of functional networks of estrogen- and c-Myc-responsive genes and their relationship to response to tamoxifen therapy in breast cancer. PLoS One. 2008;3:e2987.
31. Kemmis CM, Salvador SM, Smith KM, Welsh J. Human mammary epithelial cells express CYP27B1 and are growth inhibited by 25- hydroxyvitamin D-3, the major circulating form of vitamin D-3. J Nutr. 2006;136: 887-892.
32. Sherr CJ. Cancer cell cycles. Science. 1996;274: 1672-1677.
33. Nevins JR. E2F: a link between the Rb tumor suppressor protein and viral oncoproteins. Science. 1992;258: 424-429.
34. Leemans CR, Braakhuis BJ, Brakenhoff RH. The molecular biology of head and neck cancer. Nat Rev Cancer. 2011;11: 9-22.
35. Salehi-Tabar R, Nguyen-Yamamoto L, Tavera-Mendoza LE, et al. Vitamin D receptor as a master regulator of the c-MYC/MXD1 network. Proc Natl Acad Sci U S A. 2012;109: 18827-18832.
36. Simpson RU, Thomas GA, Arnold AJ. Identification of 1,25-dihydroxyvitamin D3 receptors and activities in muscle. J Biol Chem. 1985;260: 8882-8891.
37. Tong WM, Kállay E, Hofer H, et al. Growth regulation of human colon cancer cells by epidermal growth factor and 1,25-dihydroxyvitamin D3 is mediated by mutual modulation of receptor expression. Eur J Cancer. 1998;34: 2119-2125.
38. Mathieu C, Adorini L. The coming of age of 1,25-dihydroxyvitamin D3 analogs as immunomodulatory agents. Trends Mol Med. 2002; 8: 174-179.
39. Yoshiko Y, Hirao K, Maeda N. Differentiation in C2C12 myoblasts depends on the expression of endogenous IGFs and not serum depletion. Am J Physiol Cell Physiol. 2002;283:C1278-C1286.
40. Klotz B, Mentrup B, RegensburgerM,et al. 1,25-Dihydroxyvitamin D3treatment delays cellular aging in human mesenchymal stem cells while maintaining their multipotent capacity. PLoS One. 2012;7: e29959.
41. An BS, Tavera-Mendoza LE, Dimitrov V, et al. Stimulation of Sirt1- regulated FoxO protein function by the ligand-bound vitamin D receptor. Mol Cell Biol. 2010;30: 4890-4900.
42. Chakkalakal JV, Jones KM, Basson MA, Brack AS. The aged niche disrupts muscle stem cell quiescence. Nature. 2012;490: 355-360.
43. Artaza JN, Norris KC. VitaminDreduces the expression of collagen and key profibrotic factors by inducing an antifibrotic phenotype in mesenchymal multipotent cells. J Endocrinol. 2009;200: 207-221.
44. Luderer HF, NazarianRM,ZhuED,DemayMB.Ligand-dependent actions of the vitamin D receptor are required for activation of TGF-β signaling during the inflammatory response to cutaneous injury. Endocrinology. 2013;154: 16-24.
45. Ding N,YuRT, Subramaniam N, et al. A vitamin Dreceptor/SMAD genomic circuit gates hepatic fibrotic response. Cell. 2013;153: 601-613.
46. Zhou QG, Hou FF, Guo ZJ, Liang M, Wang GB, Zhang X. 1,25- Dihydroxyvitamin D improved the free fatty-acid-induced insulin resistance in cultured C2C12 cells. Diabetes Metab Res Rev. 2008; 24: 459-464.
47. Langelaan ML, Boonen KJ, Rosaria-Chak KY, van der Schaft DW, Post MJ, Baaijens FP. Advanced maturation by electrical stimulation: differences in response between C2C12 and primary muscle progenitor cells. J Tissue Eng Regen Med. 2011;5: 529-539.
48. Kotliar N, Pilch PF. Expression of the glucose transporter isoform GLUT 4 is insufficient to confer insulin-regulatable hexose uptake to cultured muscle cells. Mol Endocrinol. 1992;6: 337-345.
49. Alami-Durante H, Cluzeaud M, Bazin D, Mazurais D, Zambonino-Infante JL. Dietary cholecalciferol regulates the recruitment and growth of skeletal muscle fibers and the expressions of myogenic regulatory factors and the myosin heavy chain in European sea bass larvae. J Nutr. 2011;141: 2146-2151.
50. Krishnaveni GV, Veena SR, Winder NR, et al. Maternal vitamin D status during pregnancy and body composition and cardiovascular risk markers in Indian children: the Mysore Parthenon Study. Am J Clin Nutr. 2011;93: 628-635.
51. Marantes I, Achenbach SJ, Atkinson EJ, Khosla S, Melton LJ 3rd, Amin S. Is vitamin D a determinant of muscle mass and strength? J Bone Miner Res. 2011;26: 2860-2871.
52. Bouillon R, Carmeliet G, Verlinden L, et al. Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr Rev. 2008;29: 726-776.
53. Zammit PS, Heslop L, Hudon V, et al. Kinetics of myoblast proliferation show that resident satellite cells are competent to fully regenerate skeletal muscle fibers. Exp Cell Res. 2002;281: 39-49.
54. Srikuea R, Zhang X, Park-Sarge OK, Esser KA.VDRand CYP27B1 are expressed in C2C12 cells and regenerating skeletal muscle: potential role in suppression of myoblast proliferation. Am J Physiol Cell Physiol. 2012;303:C396-C405.
55. Garcia LA, Ferrini MG, Norris KC, Artaza JN. 1,25(OH)2vitamin D3 enhances myogenic differentiation by modulating the expression of key angiogenic growth factors and angiogenic inhibitors inC2C12 skeletal muscle cells. J Steroid Biochem Mol Biol. 2013;133: 1-11.